Stock Events

Stock Events

Edesa Biotech 

€0.000000
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7AugExpected
Q1 2026
Next
-0.42
-0.35
-0.29
-0.22
Expected EPS
-0.38086425
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RBTQ.STU. It's not an investment recommendation.
Tesla
4
TSLA
Netflix
4
NFLX
Apple
3
AAPL
Microsoft
3
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap31.65B
Moderna is involved in developing mRNA-based therapies, a field that overlaps with Edesa Biotech's focus on innovative treatments, making them direct competitors in the biotech space.
BioNTech
BNTX
Mkt Cap24.67B
BioNTech competes in the development of novel therapies, including mRNA vaccines and treatments, directly challenging Edesa Biotech's market.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.59B
Regeneron Pharmaceuticals is a leader in biopharmaceuticals, focusing on immunology and inflammation, areas that Edesa Biotech is also targeting.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences is a biopharmaceutical company with a strong presence in antiviral drugs and treatments for inflammatory and respiratory diseases, competing with Edesa Biotech's research focus.
AMGEN
AMGN
Mkt Cap201.93B
Amgen is a biotech firm with a broad portfolio, including treatments for inflammatory diseases, which puts it in competition with Edesa Biotech's therapeutic areas.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie operates in similar therapeutic areas as Edesa Biotech, including immunology and chronic diseases, making them competitors in the biopharmaceutical field.
Pfizer
PFE
Mkt Cap138.61B
Pfizer is a global pharmaceutical company with a wide range of products, including vaccines and biologics that compete with Edesa Biotech's developments.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson, through its pharmaceutical division Janssen, develops treatments that overlap with Edesa Biotech's focus areas, particularly in immunology.
Novartis
NVS
Mkt Cap305.1B
Novartis is a global healthcare company with a strong emphasis on research and development in areas like dermatology and rheumatology, competing with Edesa Biotech.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca has a diverse biopharmaceutical portfolio, including treatments for respiratory and autoimmune diseases, making it a competitor to Edesa Biotech.

About

Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
Show more...
CEO
Dr. Pardeep Nijhawan FRCPC, M.D.
Employees
16
Country
Canada
ISIN
CA27966L1085

Listings

XNAS
US
EDSA
STU
DE
RBTQ.STU
BOATS
BOATS
EDSA.BOATS

0 Comments

Share your thoughts

FAQ

What is Edesa Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Edesa Biotech stocks are traded under the ticker RBTQ.STU.
When is the next Edesa Biotech earnings date?▼
Edesa Biotech is going to release the next earnings report on August 07, 2026.
What were Edesa Biotech earnings last quarter?▼
RBTQ.STU earnings for the last quarter are -0.42 EUR per share, whereas the estimation was -0.22 EUR resulting in a -88.46% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Edesa Biotech have?▼
As of July 09, 2026, the company has 16 employees.
In which sector is Edesa Biotech located?▼
Edesa Biotech operates in the Health & Wellness sector.
When did Edesa Biotech complete a stock split?▼
Edesa Biotech has not had any recent stock splits.
Where is Edesa Biotech headquartered?▼
Edesa Biotech is headquartered in Markham, Canada.